ALNY vs SNYR · P/E 76, rev $1.29B vs rev $30.4M
Alnylam Pharmaceuticals Inc (ALNY) versus Synergy CHC Corp. Common Stock (SNYR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Synergy CHC Corp. Common Stock (SNYR) is a medical distribution company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported SNYR revenue for 2025-12-31 was $30.4M. Net income was -$12.3M. Revenue was down 12.8% from 2024-12-31 to 2025-12-31. SNYR currently screens at market cap $2.9M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. SNYR currently screens at market cap $2.9M.
Not investment advice. Open the ALNY and SNYR stock pages for the full models.
Not investment advice.